XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Apr. 01, 2023
Mar. 26, 2022
Cash flows from operating activities:    
Net earnings $ 72,345 $ 62,906
Adjustments to reconcile net earnings to net cash flows from operations:    
Depreciation and amortization 24,558 23,884
Contribution to defined benefit pension plan (15,259) 0
Stock-based compensation 8,689 9,463
Defined benefit pension plan expense (benefit) 61 (2,705)
Loss on sale of property, plant, and equipment 51 4
Equity in loss in nonconsolidated subsidiaries 821 358
Deferred income taxes 7,487 708
Changes in assets and liabilities:    
Receivables (42,175) (36,643)
Inventories 9,052 (68,236)
Prepaid expenses and other assets (current and non-current) (25,153) (4,452)
Contract assets 14,695 (19,486)
Accounts payable 4,127 49,006
Accrued expenses (36,551) (34,186)
Contract liabilities (22,559) 4,308
Other noncurrent liabilities 5,652 14
Income taxes payable / refundable 15,358 17,760
Net cash flows provided by operating activities 21,199 2,703
Cash flows from investing activities:    
Purchase of property, plant, and equipment (22,361) (27,095)
Proceeds from sale of assets 1,021 2
Other, net (449) (2,007)
Net cash flows used in investing activities (21,789) (29,100)
Cash flows from financing activities:    
Proceeds from short-term borrowings 11,090 0
Payments on short-term borrowings (5,788) (5,562)
Proceeds from long-term borrowings 125,000 97,000
Principal payments on long-term borrowings (10,796) (82,529)
Dividends paid (11,742) (10,616)
Dividends to noncontrolling interest (654) 0
Purchase of treasury shares (111,115) 0
Proceeds from exercises under stock plans 5,018 713
Purchase of common treasury shares-stock plan exercises (14,022) (2,527)
Net cash flows used in financing activities (13,009) (3,521)
Effect of exchange rate changes on cash and cash equivalents 1,141 2,386
Net change in cash and cash equivalents (12,458) (27,532)
Cash and cash equivalents-beginning of year 185,406 177,232
Cash and cash equivalents-end of period $ 172,948 $ 149,700